Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in India
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in IndiaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Ahemdabad, Bangalore, Belagavi, Dehradun, Delhi, Jaipur, Kolkata, Lucknow, Nagpur, New Delhi, Pune
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00